These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30124577)

  • 1. Clinical Correlates of Cannabis Use Among Individuals With Attention Deficit Hyperactivity Disorder.
    Brandt A; Rehm J; Lev-Ran S
    J Nerv Ment Dis; 2018 Sep; 206(9):726-732. PubMed ID: 30124577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention deficit hyperactivity disorder, other mental health problems, substance use, and driving: examination of a population-based, representative canadian sample.
    Vingilis E; Mann RE; Erickson P; Toplak M; Kolla NJ; Seeley J; Jain U
    Traffic Inj Prev; 2014; 15 Suppl 1():S1-9. PubMed ID: 25307372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey.
    Kolla NJ; van der Maas M; Toplak ME; Erickson PG; Mann RE; Seeley J; Vingilis E
    BMC Psychiatry; 2016 Feb; 16():50. PubMed ID: 26920911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.
    Schubiner H; Tzelepis A; Milberger S; Lockhart N; Kruger M; Kelley BJ; Schoener EP
    J Clin Psychiatry; 2000 Apr; 61(4):244-51. PubMed ID: 10830144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Cross-sectional Cohort Study of Prevalence, Co-Morbidities, and Correlates of Attention-deficit Hyperactivity Disorder among Adult Patients Admitted to the Li Ka Shing Psychiatric Outpatient Clinic, Hong Kong.
    Leung VM; Chan LF
    East Asian Arch Psychiatry; 2017 Jun; 27(2):63-70. PubMed ID: 28652499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily, but not occasional, cannabis use is selectively associated with more impulsive delay discounting and hyperactive ADHD symptoms in binge-drinking young adults.
    Petker T; Ferro M; Van Ameringen M; Murphy J; MacKillop J
    Psychopharmacology (Berl); 2021 Jul; 238(7):1753-1763. PubMed ID: 33638699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study.
    Chen Q; Hartman CA; Haavik J; Harro J; Klungsøyr K; Hegvik TA; Wanders R; Ottosen C; Dalsgaard S; Faraone SV; Larsson H
    PLoS One; 2018; 13(9):e0204516. PubMed ID: 30256837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in adult attention-deficit/hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
    Cortese S; Faraone SV; Bernardi S; Wang S; Blanco C
    J Clin Psychiatry; 2016 Apr; 77(4):e421-8. PubMed ID: 27137426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity in adults with attention-deficit hyperactivity disorder.
    Cumyn L; French L; Hechtman L
    Can J Psychiatry; 2009 Oct; 54(10):673-83. PubMed ID: 19835674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep, Alcohol and Cannabis Use in College Students With and Without Attention-Deficit/Hyperactivity Disorder.
    Marsh NP; Oddo LE; Murphy JG; Chronis-Tuscano A
    Subst Use Misuse; 2024; 59(8):1141-1149. PubMed ID: 38555872
    [No Abstract]   [Full Text] [Related]  

  • 11. The association between cannabis use and psychiatric comorbidity in people with personality disorders: A population-based longitudinal study.
    Shalit N; Rehm J; Lev-Ran S
    Psychiatry Res; 2019 Aug; 278():70-77. PubMed ID: 31153010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotic Symptoms in Attention-Deficit/Hyperactivity Disorder: An Analysis of the MTA Database.
    Vitiello B; Perez Algorta G; Arnold LE; Howard AL; Stehli A; Molina BS
    J Am Acad Child Adolesc Psychiatry; 2017 Apr; 56(4):336-343. PubMed ID: 28335878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3-year population-based longitudinal study.
    Feingold D; Rehm J; Factor H; Redler A; Lev-Ran S
    Depress Anxiety; 2018 Jun; 35(6):490-501. PubMed ID: 29486095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of cannabis use disorder in attention-deficit hyperactivity disorder: A clinical epidemiological meta-analysis.
    Froude AM; Fawcett EJ; Coles A; Drakes DH; Harris N; Fawcett JM
    J Psychiatr Res; 2024 Apr; 172():391-401. PubMed ID: 38452637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis.
    Mosandl CF; Baltes-Flückiger L; Kronschnabel J; Meyer M; Guessoum A; Herrmann O; Vogel M; Walter M; Pichler EM
    Front Public Health; 2024; 12():1356988. PubMed ID: 38841675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
    Nierenberg AA; Miyahara S; Spencer T; Wisniewski SR; Otto MW; Simon N; Pollack MH; Ostacher MJ; Yan L; Siegel R; Sachs GS;
    Biol Psychiatry; 2005 Jun; 57(11):1467-73. PubMed ID: 15950022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between attention-deficit hyperactivity disorder symptoms and problem gambling: A mediation analysis of influential factors among 7,403 individuals from the UK.
    Jacob L; Haro JM; Koyanagi A
    J Behav Addict; 2018 Sep; 7(3):781-791. PubMed ID: 30238788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtypes of attention deficit-hyperactivity disorder (ADHD) and cannabis use.
    Loflin M; Earleywine M; De Leo J; Hobkirk A
    Subst Use Misuse; 2014 Mar; 49(4):427-34. PubMed ID: 24093525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of attention deficit/hyperactivity disorder symptoms in outpatient adolescents and young adults with other psychiatric disorders refractory to previous treatments].
    Vidal R; Barrau V; Casas M; Caballero-Correa M; Martínez-Jiménez P; Ramos-Quiroga JA
    Rev Psiquiatr Salud Ment; 2014; 7(3):104-12. PubMed ID: 24931103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-morbidity of attention deficit hyperactivity disorder among children with seizure disorders at University of Gondar referral hospital Ethiopia (2016).
    Mulat H; Yegezaw N; Eyasu T
    Sci Rep; 2021 Aug; 11(1):16368. PubMed ID: 34385491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.